BARWON HEALTH
- Country
- ๐ฆ๐บAustralia
- Ownership
- Private
- Established
- 1998-01-01
- Employees
- 5K
- Market Cap
- -
Telacebec (T) Treatment in Adults With Buruli Ulcer (BU).
- First Posted Date
- 2024-07-01
- Last Posted Date
- 2025-01-24
- Lead Sponsor
- Barwon Health
- Target Recruit Count
- 40
- Registration Number
- NCT06481163
- Locations
- ๐ฆ๐บ
Barwon Health, Geelong, Victoria, Australia
๐ฆ๐บRoyal Melbourne Hospital, Melbourne, Australia
A Feasibility Study Of NAB-Paclitaxel In Combination With Carboplatin As First Line Treatment Of Gastrointestinal Neuroendocrine Carcinomas
- Conditions
- Gastrointestinal Neuroendocrine Carcinomas
- Interventions
- First Posted Date
- 2014-08-13
- Last Posted Date
- 2017-11-22
- Lead Sponsor
- Barwon Health
- Target Recruit Count
- 4
- Registration Number
- NCT02215447
- Locations
- ๐ฆ๐บ
Royal Melbourne Hospital, Parkville, Victoria, Australia
๐ฆ๐บBarwon Health, Geelong, Victoria, Australia
๐ฆ๐บRoyal North Shore Hospital, St Leonards, New South Wales, Australia
IST Neoadjuvant Abraxane in Newly Diagnosed Breast Cancer
- First Posted Date
- 2013-04-12
- Last Posted Date
- 2017-07-02
- Lead Sponsor
- Barwon Health
- Target Recruit Count
- 60
- Registration Number
- NCT01830244
- Locations
- ๐ฆ๐บ
Bankstown Lidcome Hospital, Bankstown, New South Wales, Australia
๐ฆ๐บSt John of God Healthcare, Geelong, Geelong, Victoria, Australia
๐ฆ๐บBarwon Health, Geelong, Victoria, Australia
A Feasibility Trial Using Lithium As A Neuroprotective Agent In Patients Undergoing Prophylactic Cranial Irradiation For Small Cell Lung Cancer
- First Posted Date
- 2011-12-06
- Last Posted Date
- 2015-03-18
- Lead Sponsor
- Barwon Health
- Target Recruit Count
- 7
- Registration Number
- NCT01486459
- Locations
- ๐ฆ๐บ
Barwon Health, Geelong, Victoria, Australia
๐ฆ๐บPeter MacCallum Cancer Centre, Moorabbin, Victoria, Australia
A Pilot Study to Assess the Follow-up of Prostate Cancer Patients Who Have Undergone Radiotherapy Treatment
- Conditions
- Prostate Cancer
- First Posted Date
- 2009-01-16
- Last Posted Date
- 2017-02-02
- Lead Sponsor
- Barwon Health
- Target Recruit Count
- 107
- Registration Number
- NCT00823771
- Locations
- ๐ฆ๐บ
Andrew Love Cancer Centre, Geelong, Victoria, Australia
Thyroid-Associated Ophthalmopathy Subtypes and Orbital Antibodies
- Conditions
- Graves' Ophthalmopathy
- First Posted Date
- 2007-02-02
- Last Posted Date
- 2007-02-02
- Lead Sponsor
- Barwon Health
- Target Recruit Count
- 60
- Registration Number
- NCT00430547
- Locations
- ๐ฆ๐บ
Barwon Health - The Geelong Hospital, Geelong, Victoria, Australia
Bisphosphonate and Anastrozole Trial - Bone Maintenance Algorithm Assessment
- First Posted Date
- 2005-07-22
- Last Posted Date
- 2013-03-13
- Lead Sponsor
- Barwon Health
- Target Recruit Count
- 303
- Registration Number
- NCT00122356
- Locations
- ๐ฆ๐บ
South West Healthcare, Warrnambool, Victoria, Australia
๐ฆ๐บSydney South West Area Health Service, Sydney, New South Wales, Australia
๐ฆ๐บSt Vincent's Health, Fitzroy, Victoria, Australia